What is PocDoc?
PocDoc is revolutionizing healthcare by enabling individuals to conduct comprehensive disease testing using just a smartphone or tablet and a fingerprick of blood. The platform provides detailed health assessments, contextualizing results and offering solutions for identified health issues. Its proprietary quantitative blood tests are primarily focused on preventative areas such as Cardiovascular Disease and Diabetes. PocDoc's technology also supports the integration of existing rapid tests, digitizing their results for similar assessment and care pathways. The company demonstrated its capability by successfully deploying its platform to digitize lateral flow tests during the pandemic, partnering with NHS Digital and the Department of Health. Furthermore, PocDoc has collaborated with PATH to support polio eradication efforts in remote areas, facilitating digital testing far from traditional pathology labs.
How much funding has PocDoc raised?
PocDoc has raised a total of $6.2M across 1 funding round:
Other Financing Round
$6.2M
Other Financing Round (2024): $6.2M with participation from Molten, Simplyhealth Group, and MMC Ventures
Key Investors in PocDoc
Molten
Molten, likely a venture capital firm, is participating in this funding round, bringing potential expertise in scaling technology companies.
Simplyhealth Group
Simplyhealth Group, a long-standing provider of everyday health products and services, brings a deep understanding of the healthcare landscape and a commitment to improving public health.
MMC Ventures
MMC Ventures is a venture capital firm known for backing transformative technology companies from the Seed and Series A stages, suggesting a focus on PocDoc's innovative technology and market disruption potential.
What's next for PocDoc?
With this substantial enterprise-level backing and a recent major strategic investment, PocDoc is poised for significant expansion. The company's focus on preventative healthcare, coupled with its innovative digital platform and proprietary testing capabilities, positions it for accelerated growth. Future developments are likely to involve scaling its operations, further enhancing its platform's diagnostic capabilities, and forging new partnerships to broaden its impact in both chronic disease management and global health initiatives. The strategic nature of the recent financing suggests a focus on market penetration and the development of new service offerings.
See full PocDoc company page
